Fundamentals of Glucose and Insulin Management Before, During, and After Exercise for Patients with T1D
Aaron J. Kowalski, PhD
President and CEO
New York, NY
Joseph Henske, MD, FACE
Director of the Diabetes Program
Division of Diabetes, Endocrinology, and Metabolism
University of Arkansas for Medical Sciences
Little Rock, AR
Lori Laffel, MD, MPH
Harvard Medical School
Chief, Pediatric, Adolescent and Young Adult Section
Head, Section on Clinical, Behavioral and Outcomes Research
Joslin Diabetes Center
Ian Gallen, MD, CBE
Royal Berkshire FT and Community Diabetes Specialist
Berkshire West CCGs
Michael Riddell, PhD
School of Kinesiology and Health Science
Muscle Health Research Centre
Iñigo San Millán, PhD
Associate Research Professor
Department of Human Physiology and Nutrition
University of Colorado, Colorado Springs
Division of Endocrinology, Metabolism and Diabetes
Division of Sports Medicine
University of Colorado School of Medicine
Becky Sulik, RD, LD, CDE
Director of Education
Rocky Mountain Diabetes & Osteoporosis Center
Idaho Falls, ID
Co-founder & President, Diabetes Sports Project
San Marcos, CA
Sara C. Miller, MS, CPHQ
Director, QI Institute, CE Strategy and Content
Kathryn Schaefer, MSN, RN, CPHRM
Senior Manager, Accreditation and Compliance
East Lansing, MI
Upon completion, participants should be able to:
- Discuss management of insulin and nutrition required for different forms of exercise
- Outline strategies for managing insulin and carbohydrate intake in order to minimize the risk of hypoglycemia
This activity is intended for the healthcare team caring for those living with type 1 diabetes, including diabetologists, adult and pediatric endocrinologists, primary care physicians, endocrinology advanced practice providers, pharmacists, nurses, dietitians, CDEs, and other healthcare professionals.
Statement of Need
Type 1 diabetes (T1D) is a challenging condition to manage for a number of physiologic and behavioral reasons. Regular exercise is important to help people with T1D improve health and well-being, achieve target lipid profiles, improve body composition, and reach personal goals related to fitness and glycemic control. Integrating physical activity into daily life is challenging for anyone, but those with T1D face additional barriers related to the management of blood glucose levels before, during, and after exercise, including a fear of hypoglycemia, which prevents many from starting exercise programs. People with T1D tend to be at least as inactive as the general population, with a large percentage of individuals not maintaining a healthy body mass and not achieving the minimum recommended weekly amount of moderate to vigorous aerobic activity. The PEAK program addresses the need for education on safely and successfully planning for and managing different types of activity with T1D.
This activity was developed by Med-IQ in collaboration with JDRF.
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
American Board of Internal Medicine Maintenance of Certification Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
CLAIMING MOC POINTS: If you intend to claim MOC points for your participation, you will need to provide your unique, six-digit ABIM ID Number. Please note, your name, ABIM ID number, birthdate and completion status will be shared with ABIM through the ACCME PARS system. Your points will be automatically submitted to the ABIM on your behalf; please allow 4 weeks for your points to display on the ABIM website.
Med-IQ is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This nursing activity has been approved for up to 0.75 contact hour.
Med-IQ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.75 contact hour (0.075 CEUs) of credit for pharmacists. ACPE #0476-0000-19-009-H01-P. This knowledge-based activity is designed for all pharmacists.
Instructions to Receive Credit
To receive credit, read the introductory CME/CE material, watch the Webcast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
Aaron J. Kowalski, PhD, has indicated no real or apparent conflicts.
Lori Laffel, MD, MPH
Consulting fees/advisory boards: Boehringer Ingelheim Pharmaceuticals, Inc., ConvaTec, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Insulet Corporation, Insulogic, Janssen Pharmaceuticals, Laxmi Pharma Equipments, LifeScan, Medtronic, Novo Nordisk, Sanofi-aventis U.S. Inc.
Statement of Evidence-Based Content
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email email@example.com.
Operating system - Med-IQ supports the following operating systems:
- Microsoft Windows supported by Microsoft
- Mac OS supported by Apple
Browsers - Med-IQ supports the current version of each browser listed below, plus two prior versions:
Microsoft Internet Explorer
- Microsoft Edge
Operating system - Med-IQ supports the current operating system, plus two prior releases:
- Android (eg, Samsung Galaxy)
- Apple (eg, iPhone/iPad)
Browsers - Med-IQ supports the default browser for the applicable operating system release, plus two prior releases:
- Android (Chrome)
- Apple (Safari)
Applications & Software
PDF Viewer - Adobe Acrobat Reader or Adobe Reader
Adobe Flash Player - Med-IQ supports the current version, plus two prior versions
For technical assistance, please refer to our Support Manual.
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Privacy & Confidentiality
Acknowledgement of Support
This activity was funded in part by The Leona M. and Harry B. Helmsley Charitable Trust.
© 2020 JDRF
Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.